TITLE

OBESITY TREATMENTS

AUTHOR(S)
Haslam, David
PUB. DATE
October 2007
SOURCE
Pulse;10/31/2007, Vol. 67 Issue 39, p40
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The author discusses several information on treatments for obesity. The author talks about the therapeutics that can be applied in alleviating corpulence. He includes the historical background for obesity treatment including mercury, arsenic, and strychnine. At the same time, he also cites the modern and most effective therapies including orlistat, sibutramine, and rimonabant.
ACCESSION #
28458211

 

Related Articles

  • Evaluation of Safety and Anti-obese Activity of a Polyherbal Formulation -- Simlim Capsule. Shah, Bijal N.; Soni, Hardik K.; Patel, Ghanshyam R.; Patel, Pooja D.; Paranjape, Archana N. // International Journal of Pharmaceutical & Phytopharmacological R; 

    Obesity is one the most common and now considered as global health problem which triggers many other metabolic disorders. In the present study, a polyherbal formulation - Simlim Capsule was evaluated for its anti-obesity activity in high fat diet (HFD) induced male Wistar albino rats. It was...

  • New anti obesity drug for 2007. Wynyard, Ruth // New Zealand Doctor;6/14/2006, p6 

    Reports that the anti-obesity drug rimonabant will be available in the Australian market by the end of 2007. Possible availability of the drug in the U.S. in 2008; View of nutritionist and professor Jim Mann on the drug.

  • ANOREXIGENIC DRUGS IN THE TREATMENT OF OBESITY: PAST, PRESENT AND FUTURE. Ştefania, Todea; Gabriel, Hancu // Acta Medica Marisiensis;2019 Supplement, Vol. 65, p69 

    Background: Obesity is a medical condition in which the subject carries an excess weight; and represents a great problem in modern society. Obesity is related to multiple reasons, including diet, lifestyle, pathological conditions, genetic factors or the use of certain medications. It can...

  • Lipid metabolic enzymes: emerging drug targets for the treatment of obesity. Shi, Yuguang; Burn, Paul // Nature Reviews Drug Discovery;Aug2004, Vol. 3 Issue 8, p695 

    Obesity is a complex disease that is regulated by both central and peripheral mechanisms. New medicines for the treatment and prevention of obesity will need to overcome the powerful compensatory responses of the overlapping, and often redundant, networks that have evolved to safeguard efficient...

  • orlistat.  // Royal Society of Medicine: Medicines;2002, p414 

    The article presents information on orlistat which is a drug that is used as an adjunct in obesity treatment, but unlike other drugs used for obesity, it is not an appetite suppressant. Instead it is an enzyme inhibitor, blocking the normal action of the enzyme pancreatic lipase in the...

  • Obesity market looks to new drugs for boost.  // Drug Store News;1/19/2009, Vol. 31 Issue 1, p26 

    The article reports on the increase in prescriptions and sales of drugs to treat obesity and related diseases in the U.S. According to a data from IMS Health Inc., prescriptions for the generic hypertension drug lininopril went from 42.4 million in 2003 to 70.5 million in 2007. On the other...

  • Management: Part II--Drugs. Lean, Mike; Finer, Nick // BMJ: British Medical Journal (International Edition);10/14/2006, Vol. 331 Issue 7572, p794 

    The article offers a look at drug treatment for obesity. Although diet and exercise play the most important role in weight loss, effective drugs against obesity should reduce energy assimilation from food or stimulate energy expenditure. The article discusses weight loss, weight maintenance,...

  • Xenical. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p809 

    An encyclopedia entry for "Xenical" is presented. It refers to a brand name of a drug pharmacologically called orlistat. The drug Xenical is commonly used for the treatment of patients who are exhibiting symptoms of mild to moderate obesity and more on those who are already on the stage of...

  • Pharmacotherapy of Obesity: An Update. Schurgin, Sunita; Siegel, Richard D. // Nutrition in Clinical Care;Jan-Apr2003, Vol. 6 Issue 1, p27 

    There has been an epidemic of obesity in the last decade, In spite of the rising numbers of people who are overweight and obese, medical treatment of obesity is currently where medical treatment of hypertension was in the 1950s with only two Food and Drug Administration-approved medications for...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics